Peptide Blockers of the Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Amyloid β
Open Access
- 1 September 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (35), 31085-31090
- https://doi.org/10.1074/jbc.m502406200
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- The inhibitory and facilitatory actions of amyloid-
β peptides on nicotinic ACh receptors and AMPA receptorsBiochemical and Biophysical Research Communications, 2002 - Intracellular accumulation of β-amyloid1–42 in neurons is facilitated by the α7 nicotinic acetylcholine receptor in Alzheimer’s diseaseNeuroscience, 2002
- β-Amyloid Production, Aggregation, and Clearance as Targets for Therapy in Alzheimer's DiseaseCellular and Molecular Neurobiology, 2002
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Targeting small Aβ oligomers: the solution to an Alzheimer's disease conundrum?Trends in Neurosciences, 2001
- β-Amyloid peptide blocks the response of α7-containing nicotinic receptors on hippocampal neuronsProceedings of the National Academy of Sciences, 2001
- Nicotinic receptor abnormalities of Alzheimer’s disease: therapeutic implicationsBiological Psychiatry, 2001
- β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High AffinityJournal of Biological Chemistry, 2000
- The C‐Terminus of the β Protein is Critical in AmyloidogenesisaAnnals of the New York Academy of Sciences, 1993
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991